The Amniotic membrane market is expected to reach US$ 1175.2million in 2027 from US$ 667.4million in 2019. The market is estimated to grow with a CAGR of 7.5% from 2020-2027.
The growth of the market is attributed to some key driving factors such as high implementation of amniotic membranes in medical science and new developments and increased investments of amniotic membranes. However, limitations encountered while using amniotic membranes in emerging nations are expected to obstruct the growth of the market to a certain extent during the forecast years.
The amniotic membrane is the innermost fetal layer, lining the amniotic cavity and protecting the fetus during pregnancy. The outer layer, termed chorionic membrane, further separates the fetus from maternal tissues. Various researches focusing on the physiological functions of fetal layers have shown that amniotic membrane not only provides physical support for the fetus but also serves as a metabolically active filter through direct interaction with amniotic fluid. The translucent, avascular, low immunogenic, anti-inflammatory, anti-scarring, and wound healing properties of amniotic membrane allow this material function beyond its role in vivo and assume a wide range of applications in regenerative medicine.
The clinical use of amniotic membrane has a long history, with the first reports on its application in the treatment of skin burns and wounds more than a century ago. These ground-breaking studies played a significant role in advancing the use of an amniotic membrane in surgery, especially in areas such as the reconstruction of the corneal and conjunctival surfaces, treatment of open ulcers and traumatic wounds, and skin transplantation. In parallel, the shelf life of the amniotic membrane has been extended by irradiation, air-drying, lyophilization, cryo-preservation, and glycerol preservation techniques. These methods are expected to further expand the use of an amniotic membrane in ophthalmology to treat corneal, conjunctival and limbal lesions, burns, scars and defects as well as general surgery to reconstruct the skin, genitourinary tract and other surfaces.
Amniotic membranes also appear to have natural protective and reparative functions; they may also be used for efficient delivery of specific factors to enhance the protection or repair of damaged tissue through genetic modification.
Based on enzyme, the amniotic membrane market, by enzyme, is segmented into cryopreserved amniotic membrane, and dehydrated amniotic membrane. The cryopreserved amniotic membrane segment held the largest share of the market in 2019, whereas the dehydrated amniotic membrane segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on application, the amniotic membrane market, by application, is segmented into surgical wounds, ophthalmology, and others. The surgical wounds segment held the largest share of the market in 2019, also the segment is anticipated to register the highest CAGR in the market during the forecast period...
Based on end-user, the amniotic membrane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, research institute and academic institutes. The hospitals segment held the largest share of the market in 2019. Moreover, the ambulatory surgical centers segment is estimated to register the highest CAGR in the market during the forecast period.
Some of the major primary and secondary sources for amniotic membranes market included in the report are American Society of Plastic Surgeons, Becker's Healthcare report, and others.
Reasons to Buy
The growth of the market is attributed to some key driving factors such as high implementation of amniotic membranes in medical science and new developments and increased investments of amniotic membranes. However, limitations encountered while using amniotic membranes in emerging nations are expected to obstruct the growth of the market to a certain extent during the forecast years.
The amniotic membrane is the innermost fetal layer, lining the amniotic cavity and protecting the fetus during pregnancy. The outer layer, termed chorionic membrane, further separates the fetus from maternal tissues. Various researches focusing on the physiological functions of fetal layers have shown that amniotic membrane not only provides physical support for the fetus but also serves as a metabolically active filter through direct interaction with amniotic fluid. The translucent, avascular, low immunogenic, anti-inflammatory, anti-scarring, and wound healing properties of amniotic membrane allow this material function beyond its role in vivo and assume a wide range of applications in regenerative medicine.
The clinical use of amniotic membrane has a long history, with the first reports on its application in the treatment of skin burns and wounds more than a century ago. These ground-breaking studies played a significant role in advancing the use of an amniotic membrane in surgery, especially in areas such as the reconstruction of the corneal and conjunctival surfaces, treatment of open ulcers and traumatic wounds, and skin transplantation. In parallel, the shelf life of the amniotic membrane has been extended by irradiation, air-drying, lyophilization, cryo-preservation, and glycerol preservation techniques. These methods are expected to further expand the use of an amniotic membrane in ophthalmology to treat corneal, conjunctival and limbal lesions, burns, scars and defects as well as general surgery to reconstruct the skin, genitourinary tract and other surfaces.
Amniotic membranes also appear to have natural protective and reparative functions; they may also be used for efficient delivery of specific factors to enhance the protection or repair of damaged tissue through genetic modification.
Based on enzyme, the amniotic membrane market, by enzyme, is segmented into cryopreserved amniotic membrane, and dehydrated amniotic membrane. The cryopreserved amniotic membrane segment held the largest share of the market in 2019, whereas the dehydrated amniotic membrane segment is anticipated to register the highest CAGR in the market during the forecast period.
Based on application, the amniotic membrane market, by application, is segmented into surgical wounds, ophthalmology, and others. The surgical wounds segment held the largest share of the market in 2019, also the segment is anticipated to register the highest CAGR in the market during the forecast period...
Based on end-user, the amniotic membrane market is segmented into hospitals, ambulatory surgical centers, specialty clinics, research institute and academic institutes. The hospitals segment held the largest share of the market in 2019. Moreover, the ambulatory surgical centers segment is estimated to register the highest CAGR in the market during the forecast period.
Some of the major primary and secondary sources for amniotic membranes market included in the report are American Society of Plastic Surgeons, Becker's Healthcare report, and others.
Reasons to Buy
- To understand the NA amniotic membrane market landscape and identify market segments that are most likely to guarantee a strong returnStay ahead of the race by comprehending the ever-changing competitive landscape for amniotic membrane market.
- Efficiently plan M&A and partnership deals in NA amniotic membrane market by identifying market segments with the most promising probable sales.
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Amniotic membrane market.
- Obtain market revenue forecast for market by various segments from 2019 to 2027 in North America region
Table of Contents
1. Introduction
3. Research Methodology
4. North America Amniotic Membrane Market - Market Landscape
5. North America Amniotic Membrane Market - Key Market Dynamics
6. Amniotic Membrane Market - North America Analysis
7. North America Amniotic Membrane Market Analysis and Forecasts To 2027 - By Enzyme
8. North America Amniotic Membrane Market Analysis - By Application
9. North America Amniotic Membrane Market Analysis - By End-User
10. Amniotic Membrane Market Revenue and Forecasts To 2027 - Geographical Analysis
11. Impact Of COVID-19 Pandemic on North America Amniotic Membrane Market
12. Company Profiles
13. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Surgenex, LLC
- Amnio Technology, LLC
- Katena Products. Inc
- Amniox Medical, Inc
- Smith & Nephew
- Organogenesis Inc
- MiMedx
- Skye Biologics Inc.
- Integra Life Sciences Corporation
- Applied Biologics LLC
